Delivery Order SPE2DB22D3011-SPE2DB24FQ1DL
Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $35K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $1,404.96 for the delivery of 4565365347 ! MENQUADFI VIAL 0.5ML. It is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 7, 2024 and was awarded on August 6, 2024. This contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The award has a potential value of $1,261.88 and a completion date of February 22, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,756.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which does not have a set-aside designation, is for the supply of 4564736964 ! MENQUADFI VIAL 0.5ML medical products. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564017415 MENQUADFI VIAL 0.5ML. The contract has a ceiling value of $10,537.20 and a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to deliver...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564387961 MENQUADFI VIAL 0.5ML. The $52,597.90 fixed-price delivery order has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying pharmaceuticals and medical supplies to support military...
- The U.S. government awarded a Delivery Order contract valued at $156,131.50 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a completion date of June 18, 2024, is for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA through December 2025...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a ceiling value of $16,554.44 and a firm fixed price pricing type. The ultimate completion date is June 17, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,680.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract, which does not have a set-aside designation, is for the provision of pharmaceutical and medical supplies to the DLA Troop Support Medical program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...